FDA grants fast track status to Aclaris drug for lichen planus
Go back to FDA grants fast track status to Aclaris drug for lichen planus| (NASDAQ: ACRS) | Delayed: 5.78 -0.08 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.86 | 52 Week High | $33.88 | |||
| Open | $5.82 | 52 Week Low | $14.12 | |||
| Day High | $5.86 | P/E | N/A | |||
| Day Low | $5.64 | EPS | $0.00 | |||
| Volume | 666,223 | |||||
